Pharmaceutical Industry

Moses & Singer has an in-depth knowledge of the many complicated issues that face today's pharmaceutical companies in the manufacture, marketing, and protection of products, as well as the issues faced by pharmaceutical entities in complying with the web of regulations and compliance guidelines applicable to them.

Attorneys at Moses & Singer have written and lectured frequently on research issues, including the effects of the HIPAA regulations, the interplay between HIPAA, FDA regulations and the Common Rule, and the role of IRBs in research compliance. Our attorneys advise clients on ongoing compliance with these issues, and possess the necessary expertise to assist in keeping pharmaceutical companies current in their understanding of the ever-changing legal landscape. Additionally, Moses & Singer attorneys help pharmaceutical companies develop clinical trials, and advise on issues related to research contracting and intellectual property.

Moses & Singer has also worked closely with various healthcare entities in developing compliance programs in order to comply with Compliance Program Guidance issued by the Office of Inspector general of the U.S. Department of Health and Human Services (OIG). Our attorneys have performed recommended risk analysis and developed strategies for corrective action, including the formulation and drafting of compliance plans, policies, procedures and training materials that comply with OIG recommendations.

For more information please contact us.

Prior results do not guarantee a similar outcome.

Overview

Moses & Singer has an in-depth knowledge of the many complicated issues that face today's pharmaceutical companies in the manufacture, marketing, and protection of products, as well as the issues faced by pharmaceutical entities in complying with the web of regulations and compliance guidelines applicable to them.

Attorneys at Moses & Singer have written and lectured frequently on research issues, including the effects of the HIPAA regulations, the interplay between HIPAA, FDA regulations and the Common Rule, and the role of IRBs in research compliance. Our attorneys advise clients on ongoing compliance with these issues, and possess the necessary expertise to assist in keeping pharmaceutical companies current in their understanding of the ever-changing legal landscape. Additionally, Moses & Singer attorneys help pharmaceutical companies develop clinical trials, and advise on issues related to research contracting and intellectual property.

Moses & Singer has also worked closely with various healthcare entities in developing compliance programs in order to comply with Compliance Program Guidance issued by the Office of Inspector general of the U.S. Department of Health and Human Services (OIG). Our attorneys have performed recommended risk analysis and developed strategies for corrective action, including the formulation and drafting of compliance plans, policies, procedures and training materials that comply with OIG recommendations.

For more information please contact us.

Prior results do not guarantee a similar outcome.